Gain greater translational insights with pre-qualified assay-ready models
InSphero assay-ready 3D InSight™ Tumor Microtissues are designed to simplify and accelerate oncology drug efficacy testing. Using the 3D Select™ Process, our oncology experts have identified optimal culture conditions for large-scale, reproducible production of 3D spheroid models that better reflect complex tumor biology.
- Leverage physiologically relevant 3D tumor co-cultures composed of tumor and stromal components — with no artificial matrices
- Assess single agent or combinatorial efficacy of small molecule, biological, ADC, or immunomodulatory drugs using 3D optimized endpoints
- Quality controlled pre-validated models that optimize your staff resources and ensure robuts, reproducible results

N87-GFP tumor model in co-culture with NIH3T3-RFP fibroblasts. Our 3D tumor assay-ready models are generated by self-assembly of tumor and stromal cells without the use of artifical matrices. (Imaged on a Yokogawa high-content screening system.)
Assay-Ready Tumor Microtissue Specifications
- Viability model dependent
- 96-well format, 1 tumor microtissue/well
- Produced on demand; production schedule dependent on cell line

We can produce monoculture or co-culture assay-ready tumor microtissues using the cell lines and stromal cells listed here. If you don't see the cell line you need, we can build a custom model for you.
Order Information
Tumor Microtissues (co-culture with stromal cells)
Validated Tumor Cell Lines
Tumor | Cell Line |
---|---|
Breast |
|
Colorectal |
|
Stomach |
|
Lung |
|
Kidney |
|
Prostate |
|
Pancreas |
|
Ovarian |
|
Liver |
|
R Available with RFP Label
G Available with GFP Label
Stromal Cells
Stromal Cell | Species |
---|---|
NhDF | Human |
SV-80 | Human |
CAF | Human |
NIH3T3 | Mouse |
Assay-ready Models Certified Applications
Efficacy Testing
- Single Drug Testing
- Combinatorial Drug Testing
- Tumor Relapse Assay
Immuno-oncology
- Infiltration
- Immune-mediated Tumor Cell Killing
- Antibody Penetration